Baird Medical Gains Argentine Clearance, Expands to Fifth International Market
Baird Medical received regulatory clearance for its microwave ablation systems in Argentina, adding to its portfolio that includes FDA, Indonesia, Malaysia and Vietnam approvals. Pending registrations in Egypt, Sri Lanka, the Philippines and Pakistan support its strategy to expand patient access to minimally invasive therapies across emerging markets.
1. Regulatory Clearance in Argentina
Baird Medical has obtained regulatory clearance for its minimally invasive microwave ablation (MWA) systems in Argentina, marking the company’s fifth international approval. The clearance enables deployment across Argentine healthcare facilities, expanding patient access to its thyroid and soft tissue treatment devices.
2. Expanding International Certifications
The Argentine approval follows existing certifications in the United States (FDA), Indonesia, Malaysia and Vietnam, positioning Baird Medical with a diversified regulatory footprint. Pending applications in Egypt, Sri Lanka, the Philippines and Pakistan reflect the company’s pipeline to secure additional market entries.
3. Global Growth and Market Strategy
By targeting emerging markets with rising demand for minimally invasive therapies, Baird Medical aims to drive revenue growth and strengthen its competitive position. The company’s roadmap includes formal registration efforts in multiple regions and partnerships to support adoption of its MWA technology.